Navigation Links
Biomarkers and Innovation Push Global Cancer Diagnostics Market Toward $8 Billion
Date:3/12/2008

NEW YORK, March 12 /PRNewswire/ -- The world market for in vitro diagnostic (IVD) tests for cancer is growing at nearly 11% annually and could reach nearly $8 billion by the end of 2012, according to a new study released today by Kalorama Information. In addition to demographic and epidemiologic shifts, the cancer testing market is being driven by a number of advances in traditional technologies, biomarker development, and new clinical priorities.

According to the study, The Worldwide Market for Cancer Diagnostics, 3rd Edition, the increased level of cancer screening, a public health priority as well as a healthcare cost priority, continues to drive some basic testing techniques such as fecal occult blood testing. However, advances in pharmacodiagnostic technologies aimed at refining treatment options and genetic and molecular tests to determine tumor growth pathways in the evaluation of patients at risk are creating exciting opportunities for research development and offer the potential to open new market niches.

In addition to technology, the report notes that the emergence of the new paradigm that views cancer as a chronic disease has also been a boon for IVD developers. With advances in early screening and improved therapeutics, there is more need for cancer management and monitoring tests.

"One of the most exciting aspects of the current cancer diagnostics market is the high level of collaboration we're seeing among complementary technologies," notes Shara Rosen, the author of the report. "New products will be made up of a mix of component parts from different platform companies, information technology providers, and reagent companies."

Kalorama Information's report The Worldwide Market for Cancer Diagnostics, 3rd Edition includes market size and growth forecasts to 2012; market segmentations by cancer type, IVD discipline, and geography; extensive discussions of technology development and penetration; and profiles of over 150 companies active in the segment. The report can be purchased directly from Kalorama Information by visiting http://www.kaloramainformation.com/Worldwide-Cancer-Diagnostics-1393082/.

About Kalorama Information

Kalorama Information supplies the latest in independent market research in the life sciences, as well as a full range of custom research services. For more information, contact Andrea Hiller at 212-807-2673 or press@kaloramainformation.com, or visit http://www.kaloramaInformation.com.


'/>"/>
SOURCE Kalorama Information
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Biomarkers for Mood May Alter Psychiatric Treatments
2. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
3. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer
4. New developments in biomarkers for epithelial ovarian cancer
5. Biomarkers for Alzheimers disease can be trusted in clinical trials
6. JDRF and Lilly partner to fund research to identify beta cell biomarkers
7. Biomarkers predict risk for invasive breast cancer years before the tumor develops
8. Study makes progress in zoning in on biomarkers for better colon cancer treatment
9. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
10. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
11. Surgery looks at inventions and innovations by surgeons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2017)... FL (PRWEB) , ... May 28, 2017 , ... ... of America (PPOA), is proud to announce that Sheldon K. Cho, MD, has ... interventional pain management, a specialty that concentrates on minimally invasive techniques to treat ...
(Date:5/27/2017)... ... May 27, 2017 , ... In any business, follow up ... talent of your dental team at presenting treatment, there will always be some patients ... of time and money on best practices when it comes to presenting treatment. ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... ... met this week to review more than eighty-nine grant submissions all vying ... emerging young scientists in the Parkinson’s field.     , The American Parkinson Disease Association ...
(Date:5/26/2017)... Clara, Calif. (PRWEB) , ... May 26, 2017 ... ... announces the integration of the CareFusion NOX-T3 portable sleep monitor with its Somnoware ... provides a consistent, browser-based interface for diagnostic device operations. With this platform, initializing ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the ... narrowly passed the U.S. House on May 4, would result in 23 million Americans ... continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced it has earned a spot ... 2017" list. The Company was ranked among 500 U.S. ... Employers and Healthcare Equipment and Services. The ... on an anonymous, independent survey of over 30,000 employees ...
(Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
Breaking Medicine Technology: